Halozyme TherapeuticsHALO

那斯達克 · USD
58.60
-1.37
(-2.28%)
盤中 08/01 11:40 (UTC+8)
08/01 11:40 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.81
  • 1.62
  • 2.21
  • 2.16
  • 2.30
  • 1.96
  • 2.31
  • 2.90
  • 2.98
  • 2.65
icon
  • -13.15
  • -10.66
  • 36.32
  • -2.26
  • 6.48
  • -14.85
  • 18.11
  • 25.39
  • 2.73
  • -11.12
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
264,861
298,008
290,084
231,353
195,879
230,039
216,033
221,038
162,143
181,496
營業成本
48,40342,05549,42639,60728,32952,29854,82350,07035,17042,120
營業毛利
216,458
255,953
240,658
191,746
167,550
177,741
161,210
170,968
126,973
139,376
營業費用
74,92380,45277,461-72,00876,70672,93176,51073,17164,867
研發費用
14,79920,44118,45821,03819,11121,33617,32119,72717,97922,566
推銷及管理費用
42,36242,24941,24135,71135,13437,60835,26938,94837,35737,749
非經常性項目費用
----------
其他營業費用
17,76217,76217,76217,76217,76317,76220,34117,83517,8354,552
營業利益
141,535
175,501
163,197
117,235
95,542
101,035
88,279
94,458
53,802
74,509
其他收入及費用
6,8187,2536,4745,0324,9935,36017,9863,1922,979852
利息費用
4,5254,5404,5244,5244,5075,2204,5054,4944,5434,570
稅前純益
143,828
178,214
165,147
117,743
96,028
101,175
101,760
93,156
52,238
70,791
所得稅
25,73341,20228,13624,49819,20515,78719,92318,40212,62313,089
稅後純益
118,095
137,012
137,011
93,245
76,823
85,388
81,837
74,754
39,615
57,702
基本每股稅後盈餘(元)
0.961.081.080.730.61-0.620.570.290.43
稀釋每股稅後盈餘(元)
0.931.061.050.720.600.650.610.550.290.42
基本平均股數(千股)
123215.00126406.00126850.00127116.00126941.00-131965.00131730.00135027.00135284.00
稀釋平均股數(千股)
126644.00128980.00130134.00129222.00128887.00-134083.00133543.00137900.00138601.00
還原基本每股稅後盈餘(元)
0.961.081.080.730.61-0.620.570.290.43
還原稀釋每股稅後盈餘(元)
0.931.061.050.720.600.650.610.550.290.42
還原基本平均股數(千股)
123,215126,406126,850127,116126,941-131,965131,730135,027135,284
還原稀釋平均股數(千股)
126,644128,980130,134129,222128,887-134,083133,543137,900138,601
EBITDA(千元)
168,939202,615188,751141,399120,206126,427129,679118,67078,15684,428

大家都在看

HOT